These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15076199)

  • 1. Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    J Hypertens; 2004 Feb; 22(2):389-97. PubMed ID: 15076199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
    Fedorova OV; Agalakova NI; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol diacetate potentiates na(+)-k(+) ATPase inhibition by a putative endogenous ligand, marinobufagenin.
    Fedorova OV; Dorofeeva NA; Lopatin DA; Lakatta EG; Bagrov AY
    Hypertension; 2002 Feb; 39(2):298-302. PubMed ID: 11847201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus.
    Bagrov YY; Manusova NB; Egorova IA; Fedorova OV; Bagrov AY
    Front Biosci; 2005 Sep; 10():2257-62. PubMed ID: 15970492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
    Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
    J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.
    Anderson DE; Fedorova OV; Morrell CH; Longo DL; Kashkin VA; Metzler JD; Bagrov AY; Lakatta EG
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1248-54. PubMed ID: 18287222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
    Hauck C; Frishman WH
    Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity.
    Fridman AI; Matveev SA; Agalakova NI; Fedorova OV; Lakatta EG; Bagrov AY
    J Hypertens; 2002 Jun; 20(6):1189-94. PubMed ID: 12023690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous cardiotonic steroids in chronic renal failure.
    Kolmakova EV; Haller ST; Kennedy DJ; Isachkina AN; Budny GV; Frolova EV; Piecha G; Nikitina ER; Malhotra D; Fedorova OV; Shapiro JI; Bagrov AY
    Nephrol Dial Transplant; 2011 Sep; 26(9):2912-9. PubMed ID: 21292813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.
    Wansapura AN; Lasko V; Xie Z; Fedorova OV; Bagrov AY; Lingrel JB; Lorenz JN
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1833-9. PubMed ID: 19376809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
    Averina IV; Tapilskaya NI; Reznik VA; Frolova EV; Fedorova OV; Lakatta EG; Bagrov AY
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):19-23. PubMed ID: 17535731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the Na+/K+ ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodeling.
    Correll RN; Eder P; Burr AR; Despa S; Davis J; Bers DM; Molkentin JD
    Circ Res; 2014 Jan; 114(2):249-256. PubMed ID: 24218169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The change and significance of the Na+-K+-ATPase alpha-subunit in ouabain-hypertensive rats.
    Tian G; Dang C; Lu Z
    Hypertens Res; 2001 Nov; 24(6):729-34. PubMed ID: 11768735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vascular Na,K-ATPase activity in salt induced hypertension in Dahl rats.
    Vasdev S; Prabhakaran VM; Fernandez P; Sampson C
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):79-91. PubMed ID: 2849788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men.
    Fedorova OV; Lakatta EG; Bagrov AY; Melander O
    J Hypertens; 2015 Mar; 33(3):534-41; discussion 541. PubMed ID: 25479026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.